Studies on quinazolinones as dual inhibitors of Pgp and MRP1 in multidrug resistance

被引：28
|
作者：
Wang, SM
Ryder, H
Pretswell, I
Depledge, P
Milton, J
Hancox, TC
Dale, I
Dangerfield, W
Charlton, P
Faint, R
Dodd, R
Hassan, S
机构：
[1] Xenova Ltd, Dept Med Chem, Slough SL1 4NL, Berks, England
[2] Xenova Ltd, Dept Pharmacol, Slough SL1 4NL, Berks, England
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2002年 / 12卷 / 04期
关键词：
D O I：
10.1016/S0960-894X(01)00804-6
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The syntheses and SAR studies of various quinazolinone compounds are described for the dual inhibition of Pgp and MRP1 in multidrug resistance. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：571 / 574
页数：4
相关论文
共 50 条
  • [31] In vivo analysis of human multidrug resistance protein 1 (MRP1) activity using transient expression of fluorescently tagged MRP1
    Rajagopal, A
    Pant, AC
    Simon, SM
    Chen, Y
    CANCER RESEARCH, 2002, 62 (02) : 391 - 396
  • [32] Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2
    Keppler, D
    Leier, I
    Jedlitschky, G
    BIOLOGICAL CHEMISTRY, 1997, 378 (08) : 787 - 791
  • [33] Design and synthesis of potent and selective tricyclic isoxazole-based inhibitors of multidrug resistance protein (MRP1).
    Jungheim, LN
    Cohen, JD
    Muehl, BS
    Thrasher, KJ
    White, WT
    Norman, BH
    Gruber, JM
    Kroin, JS
    Lander, PA
    Lohman, M
    Bonjouklian, R
    York, JS
    Lin, HS
    Richett, ME
    Barnett, CJ
    Gu, RL
    Kobierski, ME
    Dantzig, AH
    Tabas, L
    Pratt, S
    Paul, DC
    Williams, DC
    Law, KL
    Self, TD
    Starling, JJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : B197 - B197
  • [34] CLINICAL SIGNIFICANCE OF THE RESISTANCE PROTEINS LRP, PGP, MRP1, MRP3, AND MRP5 IN EPITHELIAL OVARIAN CANCER
    Tosner, J.
    Sedlakova, I.
    Laco, J.
    Caltova, K.
    Cervinka, M.
    Rezac, A.
    Spacek, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (08) : 41 - 41
  • [35] Deletion of the multidrug resistance protein 1 (MRP1) gene in acute myeloid leukemia patients with inversion 16:: expression of MRP1 homologues
    van der Kolk, DM
    de Vries, EGE
    Vellenga, E
    LEUKEMIA, 2001, 15 (01) : 191 - 192
  • [36] Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 AND GST-π in human glioma
    Calatozzolo, C
    Gelati, M
    Ciusani, E
    Sciacca, FL
    Pollo, B
    Cajola, L
    Marras, C
    Silvani, A
    Vitellaro-Zuccarello, L
    Croci, D
    Boiardi, A
    Salmaggi, A
    JOURNAL OF NEURO-ONCOLOGY, 2005, 74 (02) : 113 - 121
  • [37] Clinical Significance of the Resistance Proteins LRP, Pgp, MRP1, MRP3, and MRP5 in Epithelial Ovarian Cancer
    Sedlakova, Iva
    Laco, Jan
    Caltova, Katerina
    Cervinka, Miroslav
    Tosner, Jindrich
    Rezac, Adam
    Spacek, Jiri
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (02) : 236 - 243
  • [38] Deletion of the multidrug resistance protein 1 (MRP1) gene in acute myeloid leukemia patients with inversion 16: expression of MRP1 homologues
    DM van der Kolk
    EGE de Vries
    E Vellenga
    Leukemia, 2001, 15 : 191 - 192
  • [39] The multidrug resistance protein 1 (MRP1) - A mediator of leukotriene export in vascular cells
    Mueller, Cornelius F.
    Widder, Julian
    Wassmann, Sven
    Harrison, David
    Nickenig, Georg
    CIRCULATION, 2006, 114 (18) : 2 - 2
  • [40] Molecular cloning and pharmacological characterization of rat multidrug resistance protein 1 (MRP1)
    Nunoya, K
    Grant, CE
    Zhang, DW
    Cole, SPC
    Deeley, RG
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (08) : 1016 - 1026
12345